Adage Capital Partners Gp, L.L.C. Vera Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 480,000 shares of VERA stock, worth $13.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
480,000
Previous 1,374,000
65.07%
Holding current value
$13.3 Million
Previous $60.7 Million
66.57%
% of portfolio
0.04%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$156 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$122 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$92.7 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$82.2 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$81.9 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $751M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...